Skip to main content

APOE and BDNF polymorphisms moderate amyloid beta-related cognitive decline in preclinical Alzheimer’s disease.

Lim YY, Villemagne VL, Laws SM, Pietrzak RH, Snyder PJ, Ames D, Ellis KA, Harrington K, Rembach A, Martins RN, Rowe CC, Masters CL, Maruff P (2015)

Stay up to date with the latest news from the AIBL study.

In the spirit of reconciliation, AIBL acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea, and community. We pay our deepest respects to their Elders past, present and emerging, and extend that respect to all Aboriginal and Torres Strait Islander peoples today.

Sitemap|Copyright © 2024 AIBL | Website by Ethical Design Co.